ArticleClinics (Sao Paulo, Brazil)2026
Noninvasive ventilation use and ICU mortality in COVID-19-related acute respiratory failure: a retrospective cohort study.
Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute hypoxemic respiratory failure is a severe complication of Coronavirus Disease 2019 (COVID-19) frequently requiring Intensive Care Unit (ICU) admission. The association between Noninvasive Ventilation (NIV) and outcomes in critically ill patients remains uncertain.
objectiveTo evaluate the association between NIV use and clinical outcomes in patients with COVID-19-related acute respiratory failure.
methodsThis retrospective cohort study included adults with confirmed COVID-19 admitted to the ICU of a tertiary hospital in Porto Alegre, Brazil, between March and August 2021. Patients were categorized according to two periods with different NIV implementation strategies. Survival was evaluated using Kaplan-Meier analysis, and ICU mortality predictors were assessed using multivariable Cox regression.
resultsA total of 296 patients were included. NIV use increased between periods (2.4%vs. 77.8%; p < 0.001). The overall intubation rate was 90.5%, with no significant differences between periods (p = 0.139). Patients admitted during the second period had more severe hypoxemia and higher crude ICU mortality (58.5%vs. 43.2%; p = 0.013). In the multivariable Cox model, absence of NIV use was associated with a lower adjusted hazard of ICU mortality compared with NIV use (HR = 0.383; 95% CI 0.158-0.929; p = 0.034).
conclusionsNIV use increased markedly but was not associated with lower intubation rates. Patients receiving NIV had higher observed adjusted mortality; however, this association should not be interpreted as evidence of harm from NIV and likely reflects confounding by indication and treatment selection, as NIV was preferentially used in patients with more severe respiratory failure. Prospective studies are needed to clarify the role of NIV in critically ill patients with COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.